The Dark Side of Appetite Suppressants in Weight Loss Pharmaceuticals

This chapter examines the troubling practices of pharmaceutical companies promoting appetite-suppressing weight loss drugs while being aware of their associated risks. It highlights a significant case of fraud against a French drugmaker, shedding light on the lack of accountability and ethical responsibilities within the industry amidst high profits.